Is Banner Display?
Off
Page Content
#ffffff

ACT measured at presentation offered limited predictive value for early IRA patency in ST-segment elevation myocardial infarction (STEMI). Published in the International Journal of Cardiology, the study examined whether ACT could signal early TIMI 2–3 flow in patients pretreated with UFH.

The study included 898 adults with STEMI who received 5000 units of UFH within 120 minutes of symptom onset. Median ACT values differed only slightly between those with TIMI 0–1 flow and those achieving TIMI 2–3 flow. Higher ACT, the presence of diabetes, shorter heparin-to-catheterization intervals, and absence of hypertension were independently associated with early flow restoration.

Despite these associations, ACT showed limited predictive performance (AUC 0.612) and did not reliably identify patients with early reperfusion.

These findings suggest that ACT alone cannot accurately guide expectations of early IRA patency in STEMI, and that broader clinical variables may be needed to refine early reperfusion assessment.

Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Key highlights
  • Activated clotting time (ACT) demonstrated modest discrimination for Thrombolysis in Myocardial Infarction (TIMI) 2–3 flow, with an area under the curve (AUC) of 0.612.
  • Shorter time to unfractionated heparin (UFH), presence of diabetes mellitus (DM), and absence of hypertension (HTN) were associated with a higher likelihood of early infarct-related artery (IRA) flow.
  • Findings caution against relying on activated clotting time (ACT) alone to evaluate early reperfusion potential.
Source

Cañedo E, Carrillo-Suárez X, Fernández-Nofrerías E, et al. Association between activated clotting time and TIMI flow in STEMI patients pre-treated with unfractionated heparin. Int J Cardiol. Published online November 13, 2025. doi:10.1016/j.ijcard.2025.134007

Thumbnail
Initial ACT Provides Limited Guidance on Early Reperfusion in STEMI
Schedule Date & Time
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description

Activated clotting time showed only modest ability to identify early TIMI 2–3 flow despite routine UFH pretreatment

Release Date
Is Paid
0
Send Notification
Off